BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30289808)

  • 1. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
    AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.
    Jiang Y; Chen O; Cui C; Zhao B; Han X; Zhang Z; Liu J; Xu J; Hu Q; Liao C; Shang H
    BMC Infect Dis; 2013 Sep; 13():405. PubMed ID: 24059286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
    Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N;
    J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.
    Prakash S; Sarangi AN; Alam S; Sonawane A; Sharma RK; Agrawal S
    Gene; 2017 Dec; 637():219-229. PubMed ID: 28942035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory study.
    La D; Czarnecki C; El-Gabalawy H; Kumar A; Meyers AF; Bastien N; Simonsen JN; Plummer FA; Luo M
    PLoS One; 2011; 6(12):e29200. PubMed ID: 22216211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.
    Lisovsky I; Isitman G; Tremblay-McLean A; Song R; DaFonseca S; Lebouchẻ B; Routy JP; Bruneau J; Bernard NF
    Clin Exp Immunol; 2016 Dec; 186(3):336-346. PubMed ID: 27506421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
    Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
    Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
    Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
    J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.
    Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF
    J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
    Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
    PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
    Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
    Front Immunol; 2018; 9():1855. PubMed ID: 30147699
    [No Abstract]   [Full Text] [Related]  

  • 12. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.
    Boulet S; Kleyman M; Kim JY; Kamya P; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF
    AIDS; 2008 Jul; 22(12):1487-91. PubMed ID: 18614872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.
    Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF
    J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR3DL1 alleles and their epistatic interactions with human leukocyte antigen class I influence resistance and susceptibility to HIV-1 acquisition in the Pumwani sex worker cohort.
    Luo M; Czarnecki C; Nebroski M; Kimani J; Bernard N; Plummer FA
    AIDS; 2018 Apr; 32(7):841-850. PubMed ID: 29280757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.
    Song R; Lisovsky I; Lebouché B; Routy JP; Bruneau J; Bernard NF
    PLoS Pathog; 2014 Jan; 10(1):e1003867. PubMed ID: 24453969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
    Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
    J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population.
    Zwolińska K; Błachowicz O; Tomczyk T; Knysz B; Gąsiorowski J; Zalewska M; Orzechowska BU; Sochocka M; Piasecki E
    Immunogenetics; 2016 May; 68(5):327-37. PubMed ID: 26888639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals.
    Guerini FR; Lo Caputo S; Gori A; Bandera A; Mazzotta F; Uglietti A; Zanzottera M; Maserati R; Clerici M
    J Infect Dis; 2011 May; 203(9):1235-9. PubMed ID: 21398398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
    Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
    PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.